Bellerophon Therapeutics

+$0.21 (+5.11%) Today
$0.00 (0.00%) As of 9:40 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BLPH and other ETFs, options, and stocks.

About BLPH

Bellerophon Therapeutics, Inc. focuses on developing products at the intersection of drugs and devices that address significant unmet medical needs in the treatment of cardiopulmonary diseases. Its product pipeline include PH-ILD, PH-COPD and PH-Sarc.

CEO
Fabian Tenenbaum
Employees
21
Headquarters
Warren, New Jersey
Founded
2009

BLPH Key Statistics

Market Cap
43.93M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
121.93K
High Today
$4.37
Low Today
$4.05
Open Price
$4.10
Volume
51.63K
52 Week High
$13.87
52 Week Low
$3.79

BLPH Earnings

-$1.08
-$0.72
-$0.36
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 5, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure